SE432423B - Sett att framstella derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo/2,1-6/tiazol med anthelmintisk verkan - Google Patents

Sett att framstella derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo/2,1-6/tiazol med anthelmintisk verkan

Info

Publication number
SE432423B
SE432423B SE7703553A SE7703553A SE432423B SE 432423 B SE432423 B SE 432423B SE 7703553 A SE7703553 A SE 7703553A SE 7703553 A SE7703553 A SE 7703553A SE 432423 B SE432423 B SE 432423B
Authority
SE
Sweden
Prior art keywords
tiazol
tetrahydroimidazo
aminophenyl
anthelmintic effect
make derivatives
Prior art date
Application number
SE7703553A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703553L (sv
Inventor
J E Thorpe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7703553L publication Critical patent/SE7703553L/xx
Publication of SE432423B publication Critical patent/SE432423B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7703553A 1976-05-01 1977-03-28 Sett att framstella derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo/2,1-6/tiazol med anthelmintisk verkan SE432423B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17883/76A GB1516938A (en) 1976-05-01 1976-05-01 Halopyridylamides of m-aminotetramisole and their use as anthelmintics

Publications (2)

Publication Number Publication Date
SE7703553L SE7703553L (sv) 1977-11-02
SE432423B true SE432423B (sv) 1984-04-02

Family

ID=10102899

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703553A SE432423B (sv) 1976-05-01 1977-03-28 Sett att framstella derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo/2,1-6/tiazol med anthelmintisk verkan

Country Status (24)

Country Link
US (1) US4112102A (xx)
JP (1) JPS52133998A (xx)
AR (1) AR215629A1 (xx)
AT (1) AT355572B (xx)
BE (1) BE854073A (xx)
CA (1) CA1067082A (xx)
CH (1) CH620218A5 (xx)
CS (1) CS189598B2 (xx)
DD (1) DD130149A5 (xx)
DE (1) DE2718976A1 (xx)
DK (1) DK142583B (xx)
ES (1) ES458249A1 (xx)
FI (1) FI60712C (xx)
FR (1) FR2349592A1 (xx)
GB (1) GB1516938A (xx)
IE (1) IE45140B1 (xx)
IL (1) IL51875A0 (xx)
LU (1) LU77233A1 (xx)
NL (1) NL162389C (xx)
NZ (1) NZ183876A (xx)
PH (1) PH11989A (xx)
PT (1) PT66491B (xx)
SE (1) SE432423B (xx)
YU (1) YU102377A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041322A1 (en) * 1980-05-30 1981-12-09 Beecham Group Plc m-Pyrazolylamido tetramisole derivatives, compositions thereof, processes for production of such compounds and compositions and their use in treating helminthiasis
WO2018231704A1 (en) * 2017-06-12 2018-12-20 Dow Agrosciences, Llc 6-bromonicotinamide and processes of preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (xx) * 1964-05-11
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
GB1365515A (en) * 1971-09-03 1974-09-04 American Cyanamid Co 6-tetrahydro imidazol/2 1-b/thiazoles
CA982136A (en) * 1971-09-07 1976-01-20 Larry D. Spicer 6-(aminophenyl)-2,3,5,6-tetrahydro(2,1-b)thiazoles
JPS4839492A (xx) * 1971-09-23 1973-06-09
CH556871A (de) * 1971-09-24 1974-12-13 American Cyanamid Co Verfahren zur herstellung von substituierten 6-phenylimidazo (2,1-b)thiazolen.
FR2153206A2 (en) * 1971-09-24 1973-05-04 American Cyanamid Co Phenyl - dihydroimidazo (2,1-b) thiazole derivs - anthelmintics

Also Published As

Publication number Publication date
JPS52133998A (en) 1977-11-09
FR2349592A1 (fr) 1977-11-25
CS189598B2 (en) 1979-04-30
ES458249A1 (es) 1978-06-01
NL162389C (nl) 1980-05-16
IE45140B1 (en) 1982-06-30
JPS5713554B2 (xx) 1982-03-17
PT66491B (en) 1978-09-29
FR2349592B1 (xx) 1980-09-19
PH11989A (en) 1978-10-05
IE45140L (en) 1977-11-01
ATA305677A (de) 1979-08-15
DD130149A5 (de) 1978-03-08
CA1067082A (en) 1979-11-27
NL7704662A (nl) 1977-11-03
DK186877A (xx) 1977-11-02
DE2718976A1 (de) 1977-11-17
DK142583B (da) 1980-11-24
PT66491A (en) 1977-05-01
NL162389B (nl) 1979-12-17
AR215629A1 (es) 1979-10-31
US4112102A (en) 1978-09-05
AU2437377A (en) 1977-09-29
SE7703553L (sv) 1977-11-02
FI60712B (fi) 1981-11-30
IL51875A0 (en) 1977-06-30
AT355572B (de) 1980-03-10
YU102377A (en) 1982-06-30
FI60712C (fi) 1982-03-10
LU77233A1 (xx) 1977-08-18
FI771362A (xx) 1977-11-02
CH620218A5 (xx) 1980-11-14
GB1516938A (en) 1978-07-05
BE854073A (fr) 1977-10-28
DK142583C (xx) 1981-07-27
NZ183876A (en) 1979-03-16

Similar Documents

Publication Publication Date Title
SE439485B (sv) Sett att framstella nya alkyloximderivat av 7-aminotiazolyl-acetamidocefalosporansyra
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7803549L (sv) 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo (1,2-a)-pyrrol-1-karbonsyraderivat och sett att framstella desamma
SE7803195L (sv) Forfarande for framstellning av 1,2,4-triazinderivat med farmakologisk verkan
SE437155B (sv) Sett att framstella nya derivat av perhydro-aza-heterocykler
SE423628B (sv) Sett att framstella heterocykliska guanidinderivat med terapeutisk verkan
SE432423B (sv) Sett att framstella derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo/2,1-6/tiazol med anthelmintisk verkan
SE437026B (sv) Forfarande for framstellning av bensopyranderivat med antiallergisk verkan
SE415971B (sv) Sett att framstella substituerade bensamider med terapeutisk verkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
FI803871L (fi) Derivat av cykliska peptider
SE427835B (sv) Sett att framstella dipeptidderivat med terapeutisk verkan
SE417467B (sv) Sett att framstella elektret, samt anordning for utovande av settet
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
FI773118A (fi) Foerfarande foer framstaellning av nya derivat av 6-(m-aminofenyl)-2,3,5,6-tetrahydroimidazo-(2,1-b)tiazol
SE7702986L (sv) 5(6)-bensenringsubstituerade bensimidazol-2-karbamatderivat med anthelmintisk verkan och sett att framstella desamma
FI56317B (fi) Foerfarande foer isolering av tymosin alfa1 med immunitetpotentierande verkan
SE398118B (sv) Sett att framstella basiska derivat av 1-aryl-2-oxo-2,4,5,6,7,7a-hexahydroindoler med terapeutisk verkan
SE422938B (sv) Sett att framstella 2-substituerade 1,4-bensoidazepinderivat
SE421696B (sv) Sett att framstella 2,9-dioxatricyklo-(4,3,1,0?723,?727)-dekaner
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
FI772936A (fi) Foerfarande foer framstaellning av fenoxihydroxipropylaminer med blockerande verkan pao hjaertats beta-reseptorer